Narrow your search

Library

KU Leuven (9)

Odisee (9)

Thomas More Kempen (9)

Thomas More Mechelen (9)

UCLL (9)

ULB (9)

VIVES (9)

ULiège (8)

UGent (6)

VDIC (5)

More...

Resource type

book (9)

periodical (4)

digital (1)


Language

English (13)


Year
From To Submit

2011 (13)

Listing 1 - 10 of 13 << page
of 2
>>
Sort by

Periodical
Journal of drug delivery and therapeutics.
Year: 2011 Publisher: [Place of publication not identified] : [JDDT]

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Targeted therapies in breast cancer
Author:
ISBN: 1280699094 9786613676061 0199749752 9780199749751 9781280699092 9780199735679 0199735670 6613676063 Year: 2011 Publisher: Oxford New York Oxford University Press

Loading...
Export citation

Choose an application

Bookmark

Abstract

The development of monoclonal antibodies and other inhibitors of specific molecules, fully utilizing the insights learned from molecular techniques such as comparative microarrays and protein expression patterns, has led to the development and FDA approval of several agents for the treatment of breast cancer, such as trastuzamab (Herceptin, targeting HER-2 positive tumors) and lapatinib (Tykerb, targeting tumors with mutated/overexpressed EGFR 1 and 2). Other agents specifically targeting the estrogen receptor, the aromatose pathway and microtubule dynamics, fulvestrant (Faslodex, targeting th


Book
Targeted Therapies : Mechanisms of Resistance
Authors: ---
ISBN: 9781607614784 9781607614777 Year: 2011 Publisher: Totowa NJ Humana Press

Loading...
Export citation

Choose an application

Bookmark

Abstract

This volume explores the mechanisms of resistance to targeted therapeutics. The focus is on the cancer cell signaling network, although other mechanisms of resistance including target mutation, and new areas of study such as cancer stem cells are included.  Targeted Therapies: Mechanisms of Resistance highlights examples of changes in the signaling network in response to inhibition of a signaling event and underscores the importance in having a mechanistic understanding of the signaling network in cancer for developing effective targeted cancer therapies. Moreover, cutting edge tools to analyze the cell signaling network will be discussed. This includes the leading edge of techniques as well as computational biology and systems theory. This volume provides the reader with both an overview as well as a detailed perspective on the mechanisms of resistance to targeted therapeutics and will be of great value to the oncologist, the physician-scientist treating patients and the translational scientist working on any aspect of targeted therapeutics.


Multi
Targeted Therapies : Mechanisms of Resistance
Author:
ISBN: 9781607614784 9781607614777 Year: 2011 Publisher: Totowa, NJ Humana Press

Loading...
Export citation

Choose an application

Bookmark

Abstract

This volume explores the mechanisms of resistance to targeted therapeutics. The focus is on the cancer cell signaling network, although other mechanisms of resistance including target mutation, and new areas of study such as cancer stem cells are included. Targeted Therapies: Mechanisms of Resistance highlights examples of changes in the signaling network in response to inhibition of a signaling event and underscores the importance in having a mechanistic understanding of the signaling network in cancer for developing effective targeted cancer therapies. Moreover, cutting edge tools to analyze the cell signaling network will be discussed. This includes the leading edge of techniques as well as computational biology and systems theory. This volume provides the reader with both an overview as well as a detailed perspective on the mechanisms of resistance to targeted therapeutics and will be of great value to the oncologist, the physician-scientist treating patients and the translational scientist working on any aspect of targeted therapeutics.


Book
Targeted drug strategies for cancer and inflammation
Authors: ---
ISBN: 1489988866 144198416X 9786613469885 1441984178 128346988X Year: 2011 Publisher: New York : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The discoveries highlighted in this book parallel the emergence of innovative “molecular targeted” small molecules and monoclonal antibodies, i.e. agents that target proteins within highly activated signal transduction pathways that control proliferation.  Many of the tumor-targeted strategies described within cross the boundaries between what’s considered to be “molecular targeted” versus conventional systemic therapy.  However, the main theme of this volume is the folate receptor (FR), with much of the content focused on its basic biology and regulation as well as its exploitation for targeted therapy and diagnostic imaging.


Periodical
Journal of drug delivery
ISSN: 20903014 20903022 Year: 2011 Publisher: New York, NY Hindawi

Loading...
Export citation

Choose an application

Bookmark

Abstract


Periodical
Drug delivery and translational research.
Author:
ISSN: 21903948 2190393X Year: 2011 Publisher: New York, NY : Springer


Book
Controlled pulmonary drug delivery
Authors: ---
ISBN: 144199744X 1441997458 Year: 2011 Publisher: New York : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This distinctive text provides a toolbox for pharmaceutical scientists and those involved in product development utilizing pulmonary drug delivery systems. Uniquely focusing on aspects of control, both temporal and spatial, the text collects a broad range of interlinked chapters that provide both theoretical and practical insight.   Controlled Pulmonary Drug Delivery begins by examination of the foundations for pulmonary drug delivery: the macro and microstructure of the airways, lung clearance, airway absorption and transport, aerosol physics, and a historical overview of the field. Unlike other texts, these chapters are written specifically with drug delivery in mind. The science and technology of inhaler devices, technologies, materials, and particles systems are covered. Testing methods and techniques are discussed before regulatory perspectives and performance specifications conclude the text. The twenty two novel chapters in this volume each provide a theoretical and practical set of tools that comprise a comprehensive toolbox.   This volume will be of interest to scientists and engineers developing pulmonary drug delivery systems. The unique themes of controlled release science and technology that run through the book ensure that experienced and newcomers will greatly benefit from this book. As the importance for control over therapeutic performance is better recognized and demanded, this text will be essential for those delivering bioactives to the lung. Dr. Hugh Smyth is Assistant Professor of Pharmaceutics at the University of Texas, Austin. He is a recipient of the Young Investigator in Pharmaceutics and Pharmaceutical Technology Award of the American Association of Pharmaceutical Scientists and has edited a volume on pulmonary drug delivery. Drs. Hickey and Smyth share a research interest in the delivery of drugs to the lungs for the treatment and prevention of a number of diseases. Dr. Anthony Hickey is Professor of Molecular Pharmaceutics and Biomedical Engineering at the University of North Carolina at Chapel Hill. He is a fellow of the Institute of Biology, American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. He has published several edited and authored volumes in the fields of pharmaceutical aerosols, process engineering and particulate science.


Book
Targeted therapies : mechanisms of resistance
Author:
ISBN: 1607614774 1607614782 Year: 2011 Publisher: New York : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This volume explores the mechanisms of resistance to targeted therapeutics. The focus is on the cancer cell signaling network, although other mechanisms of resistance including target mutation, and new areas of study such as cancer stem cells are included.  Targeted Therapies: Mechanisms of Resistance highlights examples of changes in the signaling network in response to inhibition of a signaling event and underscores the importance in having a mechanistic understanding of the signaling network in cancer for developing effective targeted cancer therapies. Moreover, cutting edge tools to analyze the cell signaling network will be discussed. This includes the leading edge of techniques as well as computational biology and systems theory. This volume provides the reader with both an overview as well as a detailed perspective on the mechanisms of resistance to targeted therapeutics and will be of great value to the oncologist, the physician-scientist treating patients and the translational scientist working on any aspect of targeted therapeutics.

Listing 1 - 10 of 13 << page
of 2
>>
Sort by